The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Statistics
Follow this link to access the full text of the article
Original article
Reduction of norepinephrine versus vasopressin in the stabilization phase of septic shock: RENOVA clinical trial
Reducción de noradrenalina frente a vasopresina en la fase de estabilización del shock séptico: ensayo clínico RENOVA
Cássio Mallmanna,b,
, Thizá Maria Bianchi Galiottoc, Michele Salibe de Oliveirab, Rafael Barberena Moraesa,c,d
Corresponding author
a Postgraduate Program in Pulmonary Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
b Intensive Care Unit, Nossa Senhora da Conceição Hospital, Conceição Hospital Group, Porto Alegre, Brazil
c Intensive Care Unit, Fêmina Hospital, Conceição Hospital Group, Porto Alegre, Brazil
d Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil


